Skip to content

RECENT ADVANCES IN HUMAN GENOME EDITING WITHIN THE FRAMEWORK OF THE "1000 YEARS OF HUMAN LIFE" PROJECT USING PRIME EDITING APPLICATIONS.

Jul 2026 · ILE MULTIDISCIPLINARY JOURNAL · Vol 5 · 0 citations

TL;DR

Due to its high precision and efficiency, the Cas9 protein, derived from the CRISPR type II system, has found wide application in various fields of science - from medicine and biotechnology to agriculture and basic research.

Abstract

The discovery of clustered regularly interspaced short palindromic repeats (CRISPR) and their interaction with CRISPR-associated protein (Cas) genes was one of the greatest scientific breakthroughs of the century. The system was discovered as part of the adaptive immunity of bacteria and archaea, protecting them from plasmids and phages. CRISPR is considered a modern alternative to zinc finger nucleases (ZFN) and TALEN nucleases, because the same protein system, Cas9, is used to edit different genes - it is enough to change the short guide RNA to direct the enzyme to the desired DNA region. Due to its high precision and efficiency, the Cas9 protein, derived from the CRISPR type II system, has found wide application in various fields of science - from medicine and biotechnology to agriculture and basic research. Keywords: CRISPR–Cas9; gene editing; prime editing

View source

Similar papers

Open access Jul 2026

Rational and computation-assisted engineering of a compact and efficient StaCas9 genome editor

Natural variation in PAM recognition among SaCas9 orthologs is analyzed and StaCas9 is identified as a compact and efficient nuclease recognizing an NNG PAM, establishing StaCas9 as a high-performance genome-editing tool for therapeutic applications.

Miao-Miao Li, Wenni You, Yuwen Tian et al. · 1 citation
#gene editing Review Open access Aug 2026

CRISPR gene therapy: a review

Clinical applicability is limited by issues such off-target effects, PAM sequence restrictions, DNA damage-induced toxicity, and immunological responses to Cas proteins, despite its wide therapeutic potential, but improvements in delivery methods and high-fidelity Cas9 variations are being addressed.

Sanjeyan N., G. G., H. S et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.